Tris(2-methyl-1-aziridinyl)phosphine oxide.
D000818:Animals; D001254:Astrocytoma / Q000139:chemically induced; D001388:Aziridines / Q000633:toxicity*; D001389:Azirines / Q000633:toxicity*; D002273:Carcinogens; D004353:Drug Evaluation, Preclinical; D005260:Female; D005333:Fetus; D005799:Genes, Dominant; D005804:Genes, Lethal; D007928:Lethal Dose 50; D007938:Leukemia / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000139:chemically induced; D008297:Male; D008431:Maternal-Fetal Exchange; D051379:Mice; D011247:Pregnancy; D051381:Rats; D013723:Teratogens
D001388:Aziridines; D001389:Azirines; D002273:Carcinogens; D013723:Teratogens